 | • レポートコード：MRC22NVL19486 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年のユビキチン酵素の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界のユビキチン酵素市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界のユビキチン酵素市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国のユビキチン酵素市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界のユビキチン酵素市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州のユビキチン酵素の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要なユビキチン酵素プレーヤーとして、3SBio、 5AM Ventures、 Abbiotec、 Abcam、 AcelRx Pharmaceuticals、 Aegera Therapeutics、 Aeneas Ventures、 Agilis Biotherapeutics、 Aileron Therapeutics、 Aju IB Investment、 Alexion Pharmaceuticals、 Almac Discovery、 Amgen、 Angelman Syndrome Foundation、 Apeiron Biologics、 Boston Biochem、 BPS Biosciences、 Business Development Bank of Canaなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとのユビキチン酵素市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ ユビキチン活性化酵素（E1）、ユビキチン結合酵素（E2）、ユビキチンリガーゼ（E3） 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ がん、生体工学、消化器病学、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：ユビキチン酵素の年間販売量2017-2028、地域別現状・将来分析 ・ユビキチン酵素のタイプ別セグメント：ユビキチン活性化酵素（E1）、ユビキチン結合酵素（E2）、ユビキチンリガーゼ（E3） ・ユビキチン酵素のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・ユビキチン酵素の用途別セグメント：がん、生体工学、消化器病学、その他 ・ユビキチン酵素の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界のユビキチン酵素市場 ・企業別のグローバルユビキチン酵素市場データ：2020-2022年の年間販売量、市場シェア ・企業別のユビキチン酵素の年間売上：2020-2022年の売上、市場シェア ・企業別のユビキチン酵素販売価格 ・主要企業のユビキチン酵素生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 ユビキチン酵素の地域別レビュー ・地域別のユビキチン酵素市場規模2017-2022：年間販売量、売上 ・主要国別のユビキチン酵素市場規模2017-2022：年間販売量、売上 ・南北アメリカのユビキチン酵素販売の成長 ・アジア太平洋のユビキチン酵素販売の成長 ・欧州のユビキチン酵素販売の成長 ・中東・アフリカのユビキチン酵素販売の成長 南北アメリカ市場 ・南北アメリカの国別のユビキチン酵素販売量、売上（2017-2022） ・南北アメリカのユビキチン酵素の種類別販売量 ・南北アメリカのユビキチン酵素の用途別販売量 ・米国のユビキチン酵素市場 ・カナダのユビキチン酵素市場 ・メキシコのユビキチン酵素市場 ・ブラジルのユビキチン酵素市場 アジア太平洋市場 ・アジア太平洋の国別のユビキチン酵素販売量、売上（2017-2022） ・アジア太平洋のユビキチン酵素の種類別販売量 ・アジア太平洋のユビキチン酵素の用途別販売量 ・中国市場のユビキチン酵素市場 ・日本市場のユビキチン酵素市場 ・韓国市場のユビキチン酵素市場 ・東南アジアのユビキチン酵素市場 ・インドのユビキチン酵素市場 ・オーストラリアのユビキチン酵素市場 ・台湾のユビキチン酵素市場 欧州市場 ・欧州の国別のユビキチン酵素販売量、売上（2017-2022） ・欧州のユビキチン酵素の種類別販売量 ・欧州のユビキチン酵素の用途別販売量 ・ドイツのユビキチン酵素市場 ・フランスのユビキチン酵素市場 ・イギリスのユビキチン酵素市場 ・イタリアのユビキチン酵素市場 ・ロシアのユビキチン酵素市場 中東・アフリカ市場 ・中東・アフリカの国別のユビキチン酵素販売量、売上（2017-2022） ・中東・アフリカのユビキチン酵素の種類別販売量 ・中東・アフリカのユビキチン酵素の用途別販売量 ・エジプトのユビキチン酵素市場 ・南アフリカのユビキチン酵素市場 ・イスラエルのユビキチン酵素市場 ・トルコのユビキチン酵素市場 ・GCC諸国のユビキチン酵素市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・ユビキチン酵素の製造コスト構造分析 ・ユビキチン酵素の製造プロセス分析 ・ユビキチン酵素の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・ユビキチン酵素の主要なグローバル販売業者 ・ユビキチン酵素の主要なグローバル顧客 地域別のユビキチン酵素市場予測レビュー ・地域別のユビキチン酵素市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・ユビキチン酵素のタイプ別市場規模予測 ・ユビキチン酵素の用途別市場規模予測 主要企業分析 3SBio、 5AM Ventures、 Abbiotec、 Abcam、 AcelRx Pharmaceuticals、 Aegera Therapeutics、 Aeneas Ventures、 Agilis Biotherapeutics、 Aileron Therapeutics、 Aju IB Investment、 Alexion Pharmaceuticals、 Almac Discovery、 Amgen、 Angelman Syndrome Foundation、 Apeiron Biologics、 Boston Biochem、 BPS Biosciences、 Business Development Bank of Cana ・企業情報 ・ユビキチン酵素製品 ・ユビキチン酵素販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Ubiquitin Enzymes will have significant change from previous year. According to our (LP Information) latest study, the global Ubiquitin Enzymes market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ubiquitin Enzymes market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Ubiquitin Enzymes market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ubiquitin Enzymes market, reaching US$ million by the year 2028. As for the Europe Ubiquitin Enzymes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ubiquitin Enzymes players cover 3SBio, 5AM Ventures, Abbiotec, and Abcam, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ubiquitin Enzymes market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
E1 Ubiquitin Activating Enzyme
E2 Ubiquitin Crosslinking Enzyme
E3 Ubiquitin Ligase
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cancer
Biological Engineering
Gastroenterology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
3SBio
5AM Ventures
Abbiotec
Abcam
AcelRx Pharmaceuticals
Aegera Therapeutics
Aeneas Ventures
Agilis Biotherapeutics
Aileron Therapeutics
Aju IB Investment
Alexion Pharmaceuticals
Almac Discovery
Amgen
Angelman Syndrome Foundation
Apeiron Biologics
Boston Biochem
BPS Biosciences
Business Development Bank of Canada
C4 Therapeutics
Calculus Capital
Canaan Partners
Cancer Research Technology
Captor Therapeutics
Carmot Therapeutics
Cayman Chemicals
Celgene Corporation
Cell Signaling Technology
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ubiquitin Enzymes Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ubiquitin Enzymes by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ubiquitin Enzymes by Country/Region, 2017, 2022 & 2028
2.2 Ubiquitin Enzymes Segment by Type
2.2.1 E1 Ubiquitin Activating Enzyme
2.2.2 E2 Ubiquitin Crosslinking Enzyme
2.2.3 E3 Ubiquitin Ligase
2.3 Ubiquitin Enzymes Sales by Type
2.3.1 Global Ubiquitin Enzymes Sales Market Share by Type (2017-2022)
2.3.2 Global Ubiquitin Enzymes Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ubiquitin Enzymes Sale Price by Type (2017-2022)
2.4 Ubiquitin Enzymes Segment by Application
2.4.1 Cancer
2.4.2 Biological Engineering
2.4.3 Gastroenterology
2.4.4 Others
2.5 Ubiquitin Enzymes Sales by Application
2.5.1 Global Ubiquitin Enzymes Sale Market Share by Application (2017-2022)
2.5.2 Global Ubiquitin Enzymes Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ubiquitin Enzymes Sale Price by Application (2017-2022)
3 Global Ubiquitin Enzymes by Company
3.1 Global Ubiquitin Enzymes Breakdown Data by Company
3.1.1 Global Ubiquitin Enzymes Annual Sales by Company (2020-2022)
3.1.2 Global Ubiquitin Enzymes Sales Market Share by Company (2020-2022)
3.2 Global Ubiquitin Enzymes Annual Revenue by Company (2020-2022)
3.2.1 Global Ubiquitin Enzymes Revenue by Company (2020-2022)
3.2.2 Global Ubiquitin Enzymes Revenue Market Share by Company (2020-2022)
3.3 Global Ubiquitin Enzymes Sale Price by Company
3.4 Key Manufacturers Ubiquitin Enzymes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ubiquitin Enzymes Product Location Distribution
3.4.2 Players Ubiquitin Enzymes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ubiquitin Enzymes by Geographic Region
4.1 World Historic Ubiquitin Enzymes Market Size by Geographic Region (2017-2022)
4.1.1 Global Ubiquitin Enzymes Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ubiquitin Enzymes Annual Revenue by Geographic Region
4.2 World Historic Ubiquitin Enzymes Market Size by Country/Region (2017-2022)
4.2.1 Global Ubiquitin Enzymes Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ubiquitin Enzymes Annual Revenue by Country/Region
4.3 Americas Ubiquitin Enzymes Sales Growth
4.4 APAC Ubiquitin Enzymes Sales Growth
4.5 Europe Ubiquitin Enzymes Sales Growth
4.6 Middle East & Africa Ubiquitin Enzymes Sales Growth
5 Americas
5.1 Americas Ubiquitin Enzymes Sales by Country
5.1.1 Americas Ubiquitin Enzymes Sales by Country (2017-2022)
5.1.2 Americas Ubiquitin Enzymes Revenue by Country (2017-2022)
5.2 Americas Ubiquitin Enzymes Sales by Type
5.3 Americas Ubiquitin Enzymes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ubiquitin Enzymes Sales by Region
6.1.1 APAC Ubiquitin Enzymes Sales by Region (2017-2022)
6.1.2 APAC Ubiquitin Enzymes Revenue by Region (2017-2022)
6.2 APAC Ubiquitin Enzymes Sales by Type
6.3 APAC Ubiquitin Enzymes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ubiquitin Enzymes by Country
7.1.1 Europe Ubiquitin Enzymes Sales by Country (2017-2022)
7.1.2 Europe Ubiquitin Enzymes Revenue by Country (2017-2022)
7.2 Europe Ubiquitin Enzymes Sales by Type
7.3 Europe Ubiquitin Enzymes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ubiquitin Enzymes by Country
8.1.1 Middle East & Africa Ubiquitin Enzymes Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ubiquitin Enzymes Revenue by Country (2017-2022)
8.2 Middle East & Africa Ubiquitin Enzymes Sales by Type
8.3 Middle East & Africa Ubiquitin Enzymes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ubiquitin Enzymes
10.3 Manufacturing Process Analysis of Ubiquitin Enzymes
10.4 Industry Chain Structure of Ubiquitin Enzymes
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ubiquitin Enzymes Distributors
11.3 Ubiquitin Enzymes Customer
12 World Forecast Review for Ubiquitin Enzymes by Geographic Region
12.1 Global Ubiquitin Enzymes Market Size Forecast by Region
12.1.1 Global Ubiquitin Enzymes Forecast by Region (2023-2028)
12.1.2 Global Ubiquitin Enzymes Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ubiquitin Enzymes Forecast by Type
12.7 Global Ubiquitin Enzymes Forecast by Application
13 Key Players Analysis
13.1 3SBio
13.1.1 3SBio Company Information
13.1.2 3SBio Ubiquitin Enzymes Product Offered
13.1.3 3SBio Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 3SBio Main Business Overview
13.1.5 3SBio Latest Developments
13.2 5AM Ventures
13.2.1 5AM Ventures Company Information
13.2.2 5AM Ventures Ubiquitin Enzymes Product Offered
13.2.3 5AM Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 5AM Ventures Main Business Overview
13.2.5 5AM Ventures Latest Developments
13.3 Abbiotec
13.3.1 Abbiotec Company Information
13.3.2 Abbiotec Ubiquitin Enzymes Product Offered
13.3.3 Abbiotec Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Abbiotec Main Business Overview
13.3.5 Abbiotec Latest Developments
13.4 Abcam
13.4.1 Abcam Company Information
13.4.2 Abcam Ubiquitin Enzymes Product Offered
13.4.3 Abcam Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abcam Main Business Overview
13.4.5 Abcam Latest Developments
13.5 AcelRx Pharmaceuticals
13.5.1 AcelRx Pharmaceuticals Company Information
13.5.2 AcelRx Pharmaceuticals Ubiquitin Enzymes Product Offered
13.5.3 AcelRx Pharmaceuticals Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AcelRx Pharmaceuticals Main Business Overview
13.5.5 AcelRx Pharmaceuticals Latest Developments
13.6 Aegera Therapeutics
13.6.1 Aegera Therapeutics Company Information
13.6.2 Aegera Therapeutics Ubiquitin Enzymes Product Offered
13.6.3 Aegera Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Aegera Therapeutics Main Business Overview
13.6.5 Aegera Therapeutics Latest Developments
13.7 Aeneas Ventures
13.7.1 Aeneas Ventures Company Information
13.7.2 Aeneas Ventures Ubiquitin Enzymes Product Offered
13.7.3 Aeneas Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aeneas Ventures Main Business Overview
13.7.5 Aeneas Ventures Latest Developments
13.8 Agilis Biotherapeutics
13.8.1 Agilis Biotherapeutics Company Information
13.8.2 Agilis Biotherapeutics Ubiquitin Enzymes Product Offered
13.8.3 Agilis Biotherapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Agilis Biotherapeutics Main Business Overview
13.8.5 Agilis Biotherapeutics Latest Developments
13.9 Aileron Therapeutics
13.9.1 Aileron Therapeutics Company Information
13.9.2 Aileron Therapeutics Ubiquitin Enzymes Product Offered
13.9.3 Aileron Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Aileron Therapeutics Main Business Overview
13.9.5 Aileron Therapeutics Latest Developments
13.10 Aju IB Investment
13.10.1 Aju IB Investment Company Information
13.10.2 Aju IB Investment Ubiquitin Enzymes Product Offered
13.10.3 Aju IB Investment Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Aju IB Investment Main Business Overview
13.10.5 Aju IB Investment Latest Developments
13.11 Alexion Pharmaceuticals
13.11.1 Alexion Pharmaceuticals Company Information
13.11.2 Alexion Pharmaceuticals Ubiquitin Enzymes Product Offered
13.11.3 Alexion Pharmaceuticals Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Alexion Pharmaceuticals Main Business Overview
13.11.5 Alexion Pharmaceuticals Latest Developments
13.12 Almac Discovery
13.12.1 Almac Discovery Company Information
13.12.2 Almac Discovery Ubiquitin Enzymes Product Offered
13.12.3 Almac Discovery Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Almac Discovery Main Business Overview
13.12.5 Almac Discovery Latest Developments
13.13 Amgen
13.13.1 Amgen Company Information
13.13.2 Amgen Ubiquitin Enzymes Product Offered
13.13.3 Amgen Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Amgen Main Business Overview
13.13.5 Amgen Latest Developments
13.14 Angelman Syndrome Foundation
13.14.1 Angelman Syndrome Foundation Company Information
13.14.2 Angelman Syndrome Foundation Ubiquitin Enzymes Product Offered
13.14.3 Angelman Syndrome Foundation Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Angelman Syndrome Foundation Main Business Overview
13.14.5 Angelman Syndrome Foundation Latest Developments
13.15 Apeiron Biologics
13.15.1 Apeiron Biologics Company Information
13.15.2 Apeiron Biologics Ubiquitin Enzymes Product Offered
13.15.3 Apeiron Biologics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Apeiron Biologics Main Business Overview
13.15.5 Apeiron Biologics Latest Developments
13.16 Boston Biochem
13.16.1 Boston Biochem Company Information
13.16.2 Boston Biochem Ubiquitin Enzymes Product Offered
13.16.3 Boston Biochem Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Boston Biochem Main Business Overview
13.16.5 Boston Biochem Latest Developments
13.17 BPS Biosciences
13.17.1 BPS Biosciences Company Information
13.17.2 BPS Biosciences Ubiquitin Enzymes Product Offered
13.17.3 BPS Biosciences Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 BPS Biosciences Main Business Overview
13.17.5 BPS Biosciences Latest Developments
13.18 Business Development Bank of Canada
13.18.1 Business Development Bank of Canada Company Information
13.18.2 Business Development Bank of Canada Ubiquitin Enzymes Product Offered
13.18.3 Business Development Bank of Canada Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Business Development Bank of Canada Main Business Overview
13.18.5 Business Development Bank of Canada Latest Developments
13.19 C4 Therapeutics
13.19.1 C4 Therapeutics Company Information
13.19.2 C4 Therapeutics Ubiquitin Enzymes Product Offered
13.19.3 C4 Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 C4 Therapeutics Main Business Overview
13.19.5 C4 Therapeutics Latest Developments
13.20 Calculus Capital
13.20.1 Calculus Capital Company Information
13.20.2 Calculus Capital Ubiquitin Enzymes Product Offered
13.20.3 Calculus Capital Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Calculus Capital Main Business Overview
13.20.5 Calculus Capital Latest Developments
13.21 Canaan Partners
13.21.1 Canaan Partners Company Information
13.21.2 Canaan Partners Ubiquitin Enzymes Product Offered
13.21.3 Canaan Partners Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Canaan Partners Main Business Overview
13.21.5 Canaan Partners Latest Developments
13.22 Cancer Research Technology
13.22.1 Cancer Research Technology Company Information
13.22.2 Cancer Research Technology Ubiquitin Enzymes Product Offered
13.22.3 Cancer Research Technology Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Cancer Research Technology Main Business Overview
13.22.5 Cancer Research Technology Latest Developments
13.23 Captor Therapeutics
13.23.1 Captor Therapeutics Company Information
13.23.2 Captor Therapeutics Ubiquitin Enzymes Product Offered
13.23.3 Captor Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Captor Therapeutics Main Business Overview
13.23.5 Captor Therapeutics Latest Developments
13.24 Carmot Therapeutics
13.24.1 Carmot Therapeutics Company Information
13.24.2 Carmot Therapeutics Ubiquitin Enzymes Product Offered
13.24.3 Carmot Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Carmot Therapeutics Main Business Overview
13.24.5 Carmot Therapeutics Latest Developments
13.25 Cayman Chemicals
13.25.1 Cayman Chemicals Company Information
13.25.2 Cayman Chemicals Ubiquitin Enzymes Product Offered
13.25.3 Cayman Chemicals Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Cayman Chemicals Main Business Overview
13.25.5 Cayman Chemicals Latest Developments
13.26 Celgene Corporation
13.26.1 Celgene Corporation Company Information
13.26.2 Celgene Corporation Ubiquitin Enzymes Product Offered
13.26.3 Celgene Corporation Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Celgene Corporation Main Business Overview
13.26.5 Celgene Corporation Latest Developments
13.27 Cell Signaling Technology
13.27.1 Cell Signaling Technology Company Information
13.27.2 Cell Signaling Technology Ubiquitin Enzymes Product Offered
13.27.3 Cell Signaling Technology Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Cell Signaling Technology Main Business Overview
13.27.5 Cell Signaling Technology Latest Developments
14 Research Findings and Conclusion